JAK inhibitors for the treatment of adult dermatomyositis: A pilot study

Saved in:

Bibliographic Details
Published in	Journal of the American Academy of Dermatology Vol. 88; no. 4; pp. 924 - 926
Main Authors	Landon-Cardinal, Océane, Guillaume-Jugnot, Perrine, Toquet, Ségolène, Sbeih, Nabiha, Rigolet, Aude, Champtiaux, Nicolas, Dorgham, Karim, Gorochov, Guy, Meyer, Alain, Anquetil, Céline, Barete, Stéphane, Benveniste, Olivier, Allenbach, Yves
Format	Journal Article
Language	English
Published	United States Elsevier Inc 01.04.2023 Elsevier
Subjects	Adult autoimmune myopathy baricitinib dermatomyositis Dermatomyositis - drug therapy Humans interferon JAK inhibitor Janus Kinase Inhibitors - therapeutic use Life Sciences myositis Pilot Projects refractory ruxolitinib refractory autoimmune myopathy myositis baricitinib JAK inhibitor dermatomyositis ruxolitinib interferon
Online Access	Get full text
ISSN	0190-9622 1097-6787 1097-6787
DOI	10.1016/j.jaad.2022.10.055

More Information
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0190-9622 1097-6787 1097-6787
DOI:	10.1016/j.jaad.2022.10.055